Abstract
The chicken MHC is known to confer decisive resistance or susceptibility to various economically important pathogens, including the iconic oncogenic herpesvirus that causes Marek’s disease (MD). Only one classical class I gene, BF2, is expressed at a high level in chickens, so it was relatively easy to discern a hierarchy from well-expressed thermostable fastidious specialist alleles to promiscuous generalist alleles that are less stable and expressed less on the cell surface. The class I molecule BF2*1901 is better expressed and more thermostable than the closely related BF2*1501, but the peptide motif was not simpler as expected. In this study, we confirm for newly developed chicken lines that the chicken MHC haplotype B15 confers resistance to MD compared with B19. Using gas phase sequencing and immunopeptidomics, we find that BF2*1901 binds a greater variety of amino acids in some anchor positions than does BF2*1501. However, by x-ray crystallography, we find that the peptide-binding groove of BF2*1901 is narrower and shallower. Although the self-peptides that bound to BF2*1901 may appear more various than those of BF2*1501, the structures show that the wider and deeper peptide-binding groove of BF2*1501 allows stronger binding and thus more peptides overall, correlating with the expected hierarchies for expression level, thermostability, and MD resistance. Our study provides a reasonable explanation for greater promiscuity for BF2*1501 compared with BF2*1901, corresponding to the difference in resistance to MD.
| Original language | English |
|---|---|
| Pages (from-to) | 668-680 |
| Number of pages | 13 |
| Journal | Journal of Immunology |
| Volume | 210 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 1 Mar 2023 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:Copyright © 2023 by The American Association of Immunologists, Inc.
Funding
This work was supported by the National Natural Science Foundation of China Grant 81971501 and National Key R&D Program of China/National Natural Science Foundation of China Grant 2021YFC0863400. W.J.L. is supported by the Excellent Young Scientist Program of National Natural Science Foundation of China Grant 81822040. D.W.A., H.-J.W., and J.K. (and Jan Salomonsen, sadly deceased and much missed) were supported by F. Hofmann-La Roche while working at the Basel Institute for Immunology. The work by V.N., W.M., and N.T. was supported by the Biotechnology and Biological Sciences Research Council at the Pirbright Institute at Compton. J.K. is supported by an Investigator Award from Wellcome Trust Grant 110106/Z/15/Z.
| Funders | Funder number |
|---|---|
| Pirbright Institute at Compton | |
| Roche | |
| Wellcome Trust | 110106/Z/15/Z. |
| Biotechnology and Biological Sciences Research Council | |
| National Natural Science Foundation of China | 81971501 |
| National Key Research and Development Program of China | 2021YFC0863400, 81822040 |